Connect your AI

Sanara MedTech Inc. SMTI Stock-Based Comp

Stock-Based Comp at other companies

Becton, Dickinson and CompanyBDX

$58M+41.5%

StrykerSYK

$87M+3.6%

IAR

Integra LifeSciencesIART

$5.17M+176%

SolventumSOLV

$51M+4.1%

Orthofix Medical Inc.OFIX

$6.53M+1.0%

ClearPoint NeuroCLPT

$2.22M+16.2%

Other financials

Income statement

Revenue$27.8M+18.6%

Gross profit$25.9M+19.8%

Operating income$2.6M+221%

Net income$459.0K+113%

EPS (diluted)$0.05+112%

Balance sheet

Cash & equivalents$13.6M-34.3%

Total debt$48.4M+8.2%

Total equity$7.0M-80.8%

Total assets$69.3M-28.1%

Cash flow

Operating cash flow-$2.5M-23.3%

CapEx$43.8K-97.5%

Free cash flow-$2.5M+32.6%

Valuation

Market cap$216.18M-9.7%

Enterprise value$250.95M-6.5%

P/S2×-0.5×

Profitability

Gross margin92.9%+1.8pp

Operating margin6.1%+5.1pp

Net margin-31.2%-93.4pp

FCF margin-9.8%-3.5pp

Returns & leverage

Return on equity-153.7%-199pp

Debt / equity6.9×+5.7×

Current ratio2.3×-0.5×

Where this comes from

Reported directly by Sanara MedTech Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Sanara MedTech Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sanara MedTech Inc.'s stock-based comp.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is Sanara MedTech Inc.'s stock-based comp?: Sanara MedTech Inc. (SMTI) reported stock-based comp of $1.03M in Q1 2026.
How has Sanara MedTech Inc.'s stock-based comp changed year-over-year?: Sanara MedTech Inc.'s stock-based comp decreased by 21.2% year-over-year, from $1.3M to $1.03M.
What is the long-term trend for Sanara MedTech Inc.'s stock-based comp?: Over 4 years (2021 to 2025), Sanara MedTech Inc.'s stock-based comp has grown at a 17.9% compound annual growth rate (CAGR), from $2.67M to $5.15M.
What does stock-based comp mean?: Total non-cash stock-based compensation expense for equity awards (RSUs, options, ESPP), added back to net income in cash flow reconciliation.